These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25640533)

  • 1. Effect of urinary excretion on the bladder tissue distribution of fluoroquinolones in rats.
    Izawa S; Yamaoka M; Deguchi T
    J Infect Chemother; 2015 Apr; 21(4):290-5. PubMed ID: 25640533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis.
    K Hurtado F; Laureano JV; de A Lock G; Derendorf H; Dalla Costa T
    Int J Antimicrob Agents; 2014 Oct; 44(4):327-33. PubMed ID: 25218157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes.
    Yamada M; Ishikawa K; Mochizuki H; Kawai M
    Acta Ophthalmol Scand; 2006 Apr; 84(2):192-6. PubMed ID: 16637835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S
    Vet Ther; 2001; 2(2):120-8. PubMed ID: 19753704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.
    Delon A; Huguet F; Courtois P; Vierfond JM; Bouquet S; Couet W
    J Pharmacol Exp Ther; 1997 Feb; 280(2):983-7. PubMed ID: 9023315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Concentration in Rat Plasma, Bladder, and Prostate After Mirodenafil Administration in a Chronic Pelvic Ischemia Model.
    Shim JS; Bae JH
    Urology; 2016 May; 91():244.e1-5. PubMed ID: 26919966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue.
    Perletti G; Wagenlehner FM; Naber KG; Magri V
    Int J Antimicrob Agents; 2009 Mar; 33(3):206-10. PubMed ID: 19091519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone levels in healthy dog urine following a 20-mg/kg oral dose of enrofloxacin exceed mutant prevention concentration targets against Escherichia coli isolated from canine urinary tract infections.
    Daniels JB; Tracy G; Irom SJ; Lakritz J
    J Vet Pharmacol Ther; 2014 Apr; 37(2):201-4. PubMed ID: 23859001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C; Tanaka M
    J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations, pharmacokinetics and urinary excretion of gatifloxacin after single intravenous injection in buffalo calves.
    Raipuria M; Dumka VK; Sandhu HS
    Vet Res Commun; 2007 Nov; 31(8):1013-20. PubMed ID: 17273911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.
    Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I
    In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of fluoroquinolones in bacterial urinary tract infections in cats].
    Kramer S; Kietzmann M; Pankow WR
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Apr; 40(2):113-21. PubMed ID: 22526815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
    Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder wall penetration of intravesical mitomycin C in dogs.
    Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies on intravesical instillation of SM-5887, a novel anthracycline derivative for treatment of bladder carcinoma].
    Ohmori H; Tsushima T; Kobashi K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):601-6. PubMed ID: 8678519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intravesical infusion of a cobalt solution stimulates a hypoxia response, growth and angiogenesis in the rat bladder.
    Buttyan R; Chichester P; Stisser B; Matsumoto S; Ghafar MA; Levin RM
    J Urol; 2003 Jun; 169(6):2402-6. PubMed ID: 12771806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment.
    Knemeyer I; Wientjes MG; Au JL
    Cancer Chemother Pharmacol; 1999; 44(3):241-8. PubMed ID: 10453726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.